🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

Investors bullish on biotechs after Trump drug pricing speech

Published 05/18/2018, 08:21 AM
© Reuters.  Investors bullish on biotechs after Trump drug pricing speech
LLY
-
MRK
-
VRTX
-
TEVA
-
GILD
-
IBB
-
AMGN
-
BIIB
-
CELG
-
AGN
-
PFE
-
BMY
-
JNJ
-
VTRS
-
BHC
-
SHPG
-
NVS
-
GSK
-
PRGO
-
XPH
-
XBI
-
NVO
-
ABBV
-
XLV
-
PPH
-
IYH
-
IHE
-
BBH
-
PJP
-
RSPH
-
RHHBY
-
  • As any student of the healthcare equity market knows by now, money flow into biotech and healthcare funds jumped after President Trump revealed his (rather benign) plan to curb U.S. drug prices. STAT News' Adam Feuerstein reports that $819M flowed into the funds this week, the largest infusion since July of last year. Investors were apparently relieved that his plan did not include allowing Medicare to negotiate drug prices, although HHS Alex Azar disclosed that this may still be on the table.
  • Selected tickers: XLV, IBB, XBI, IHE, IYH, RYH, PJP, XPH, PPH, BBH, AMGN, BIIB, GILD, CELG, VRTX, OTCQX:RHHBY, ABBV, AGN, BMY, GSK, JNJ, LLY, MRK, NVO, NVS, PFE, SHPG, VRX, TEVA, MYL, PRGO
  • Previously: Expanding Medicare drug price negotiation? (May 15)
  • Previously: Trump speech on drug prices light on specifics (May 11)
  • Now read: AbbVie's Mavyret Could Punish Gilead Tuesday


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.